We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Up 18% and 16% in February! Are these 2 blue chips the best stocks to buy in March too?

Harvey Jones is looking for the best stocks to buy over the next few weeks and wonders whether there’s an opportunity in two recent FTSE 100 winners.

| More on:
Business manager working at a pub doing the accountancy and some paperwork using a laptop computer

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The results are in and the two best FTSE 100 stocks to buy in February were drugs maker GSK (LSE: GSK) and grocery chain Tesco (LSE: TSCO). Both are viewed as solid blue chips, offering steady price growth and a reliable stream of dividends. They’re not expected to shoot the lights out but they gave it a good try last month, climbing 18% and 16% respectively. They’ve been strong over 12 months too, up 48% and 28%, with dividends on top. Can they maintain momentum in March?

I should note that one FTSE 100 stock did outperform them both. Fund manager Schroders ended February 28% higher. That’s because it has been taken over by US institutional fund manager in a £9.9bn deal, which will take it private.

XXX

GSK shares fulfilled my hopes

I’m especially pleased with the GSK bounce, having bought the stock 18 months ago when the P/E was around eight. My shares dipped shortly after I bought them, but now I’m nicely in the black. Can it deliver more?

2025 profits, announced on 4 February, saw turnover rise 4% to £32.6bn, with core operating profit up 8% to £9.7bn. Total operating profit nearly doubled to £7.93bn. However, the board warned that growth would slow to between 3% and 5% in 2026. This is due to the expiry of an HIV drug patent and a US pricing deal with the Trump administration. GSK makes more than half its profits in the US.

Risks remain, including US tariffs, and the perennial challenge of slow and costly drug development and potential litigation. There’s also the need to replenish its long-term treatment pipeline. Healthcare is often seen as a defensive sector, but it’s far from risk-free.

Today, GSK is more expensive than when I bought it, with a P/E of 12.6 and a trailing yield of about 3%. I suspect the shares may slow from here but for investors wanting long-term exposure to a key sector, I think it’s worth considering in March.

Tesco has had a good run

Tesco is pricier, with a P/E of 17.5. This is hardly surprising given the shares have flown 115% over five years, with dividends on top. The UK grocer has cemented its market-leading position, with a 28.7% share versus Sainsbury’s at 16.2%. It has shrugged off Aldi and Lidl while absorbing higher employer’s National Insurance and two big living wage hikes.

Food price inflation is now easing, which should help margins and demand. Christmas was a tad disappointing, though. Underlying sales growth slowed, though market share still managed to hit a decade high of 29.4%. Wholesale subsidiary arm Booker is also struggling, but Tesco still expects annual adjusted operating profit at the top of its guidance range of £2.9bn to £3.1bn.

Again, I think Tesco is worth considering with a long-term view. I also think it could slow in the shorter run. Investor expectations are high, judging by that valuation. And while the cost-of-living crisis is easing, shoppers are still under the cosh.

However, rather than chasing past winners, I’ll continue my search for the best FTSE 100 stocks to buy in March. I’ve got a feeling there’s more excitement elsewhere on the index. Bring it on.

Harvey Jones has positions in GSK. The Motley Fool UK has recommended GSK, Schroders Plc, and Tesco Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Friends and sisters exploring the outdoors together in Cornwall. They are standing with their arms around each other at the coast.
Investing Articles

£503 buys 14 shares in this FTSE 250 stock that returned 23.9% annually for the last 15 years

This FTSE 250 stock has averaged a huge return for 15 years. At today's price, £503 buys 14 shares. But…

Read more »

Black woman using loudspeaker to be heard
Investing Articles

£1,000 buys 25 shares in this FTSE 100 stock that’s returned 29.2% annually for the last 10 years

This FTSE 100 mining stock has returned close to 30% a year for a decade. At 3,995p, £1,000 buys 25…

Read more »

Female student sitting at the steps and using laptop
Investing Articles

Down 47%, is this growth stock finally worth buying in May?

With a £288m order book and a hidden pipeline of defence and nuclear contracts, is this growth stock now too…

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

2 REITs yielding 7%+ to consider for passive income in 2026

A REIT backed by the NHS and another backed by Tesco and Sainsbury's with both yielding 7%+. Here's why I'm…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

Just 97 shares of this UK dividend stock generate £238 in passive income

A 5.7% yield, £238 in passive income from just 97 shares, and one of the most divisive dividend stocks on…

Read more »

ISA coins
Investing Articles

£10,000 in an ISA generates a second income of…

The London Stock Exchange is home to some of the world's most generous dividends. But how big a second income…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

Expert recommendations: 2 top income stocks yielding 7%+!

With yields of 7.2% and 7.8% respectively, these two income stocks are catching the eyes of institutional analysts. Should investors…

Read more »

Illustration of flames over a black background
Investing Articles

3 top income-focused stocks to buy in May 2026, according to experts

Looking for a stock to buy for income in May 2026? Experts have flagged these three UK dividend shares as…

Read more »